// App-Quantinova.ai

: Real world (rw) homologous recombination repair (HRR) gene mutation testing trends in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the United States (US).

Researchers

Presenter

  • Pedro C. Barata

Principal Investigators

  • Rachel Montgomery

  • Matthew Last

  • Liane Gillespie-Akar

  • Jonathan Nazari

  • Bhakti Arondekar

  • Alexander Niyazov

Medical Centers

  • Adelphi Real World, Bollington, United Kingdom

  • Tulane University, New Orleans, LA

Locations

  • United Kingdom

  • United States

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Hormone receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved